Close Menu
Chicago News Journal
    Facebook X (Twitter) Instagram
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Facebook X (Twitter) Instagram YouTube TikTok
    Chicago News JournalChicago News Journal
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • LifeStyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About us
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Privacy Policy
      • Terms and Conditions
    Chicago News Journal
    Home»Politics

    FTC sues Texas anesthesiology provider to bust monopoly

    AdminBy AdminSeptember 22, 2023 Politics
    Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram

    Federal Trade Commission Chair Lina Khan testifies before a House Judiciary Committee hearing on Oversight of the Federal Trade Commission, on Capitol Hill in Washington, D.C., July 13, 2023.
    Kevin Wurm | Reuters

    The Federal Trade Commission on Thursday sued the largest anesthesiology provider in Texas, claiming the company has wielded monopoly power to drive up prices for patients and boost its profits.

    The FTC asked a federal judge in Houston, Texas, to break up U.S. Anesthesia Partners’ alleged monopoly power and permanently bar the company from engaging in anti-competitive practices.

    The agency claims that New York-based private equity firm Welsh, Carson, Anderson & Stowe founded U.S. Anesthesia Partners in 2012 to pursue an aggressive consolidation strategy that exploited Texas’ fragmented market for anesthesiology providers.

    The FTC complaint says that Welsh Carson sought to make USAP the dominant provider in Texas by hoovering up the numerous independent practices that previously competed against one another, keeping prices lower.

    CNBC Health & Science

    Read CNBC’s latest health coverage:

    • Pfizer beats on earnings, but revenue misses as Covid product sales plummet
    • Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
    • NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies

    Welsh Carson and USAP engaged in what the companies called a “roll-up,” buying nearly every large anesthesia practice in Texas, according to the complaint.

    Since 2013, USAP has grown from 400 anesthesia providers at 45 health-care facilities to 4,500 providers at 1,100 facilities in 2021.

    USAP has established monopoly power in Houston and Dallas, the two largest cities in Texas, and a dominant position in Austin, the state’s capital, according to the complaint.

    The company has used its dominance to raise prices, raking in tens of millions of dollars, the FTC alleges.

    USAP is so powerful in Austin, Dallas and Houston that it can raise prices while still gaining market share because it is difficult for competitors to enter the market, and patients typically cannot forgo anesthesia, according to the complaint.

    Dr. Derek Schoppa, a USAP board member, told CNBC that the FTC’s complaint is based on flawed legal theories and a lack of medical understanding about anesthesiology.

    “The FTC’s intended outcome threatens to disrupt and restrict patients’ equitable access to quality anesthesia care in Texas and will negatively impact the Texas hospitals and health systems that provide care in underserved communities,” Schoppa said in a statement.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram

    You might also be interested in...

    Trump appoints committee to investigate statements by the Fed’s Lisa Cook

    October 9, 2026

    U.S. East Asian envoy says investors are overpricing Taiwan conflict risk

    October 9, 2026

    Trump says U.S. will not attack Iran before midterm election

    October 8, 2026

    Trump downplays Iran deal as U.S. readies renewed strikes

    October 8, 2026

    Rubio says Iran passed up ‘multiple’ chances for nuclear deal

    October 7, 2026

    Singapore’s Temasek warns of the ‘biggest risk’ facing markets

    October 7, 2026
    Popular Posts

    U.S. East Asian envoy says investors are overpricing Taiwan conflict risk

    Interview with LJ Evans, Author of The Moments We Chose Love

    5 Best Beard Dandruff Shampoos: Defeat the Flakes in 2026

    ‘RHOC’ Emily Simpson Comes To Blows With Husband Over Son

    ‘A Prayer for the Dying’ Interview: Johnny Flynn and More

    Britain welcomed Chinese EVs. Now it faces a difficult choice

    Categories
    • Books (2,381)
    • Business (3,362)
    • Events (32)
    • Film (258)
    • LifeStyle (2,848)
    • Music (2,716)
    • Politics (2,281)
    • Science (1,896)
    • Technology (1,788)
    • Television (4,301)
    • Uncategorized (3)
    • US News (3,213)
    Archives
    Useful Links
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Popular Posts
    • Probable cause for Trump admin contempt in deportation caseProbable cause for Trump admin contempt in deportation case
    • Starfield’s Performance on Xbox Consoles Is Reportedly Way Better Than Past Bethesda Games
    • Machinists prepare for lengthy stoppageMachinists prepare for lengthy stoppage
    • The Post-Thanksgiving Reset Every Trainer Recommends — And It Only Takes 48 Hours to Feel BetterThe Post-Thanksgiving Reset Every Trainer Recommends — And It Only Takes 48 Hours to Feel Better
    • WWE founder Vince McMahon charged by SEC over settlementsWWE founder Vince McMahon charged by SEC over settlements
    Archives
    Categories
    • Books
    • Business
    • Events
    • Film
    • LifeStyle
    • Music
    • Politics
    • Science
    • Technology
    • Television
    • Uncategorized
    • US News
    Facebook X (Twitter) Instagram YouTube TikTok
    © 2026 Chicago News Journal. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms of Use and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.